share_log

Capricor Therapeutics Q1 EPS $(0.23) Up From $(0.30) YoY, Sales $40.82K Down From $185.69K YoY

Capricor Therapeutics Q1 EPS $(0.23) Up From $(0.30) YoY, Sales $40.82K Down From $185.69K YoY

Capricor Treeutics第一季度每股收益从0.30美元上升到0.23美元,销售额从185.69K美元下降到40.82K美元
Benzinga Real-time News ·  2021/05/13 15:20

Capricor Therapeutics (NASDAQ:CAPR) reported quarterly losses of $(0.23) per share. This is a 23.33 percent increase over losses of $(0.30) per share from the same period last year. The company reported $40.82 thousand in sales this quarter. This is a 78.02 percent decrease over sales of $185.69 thousand the same period last year.

Capricor治疗公司(纳斯达克市场代码:CAPR)公布季度每股亏损0.23美元。这比去年同期每股亏损0.30美元增加了23.33%。该公司报告本季度销售额为40.82万美元。这比去年同期185.69万美元的销售额下降了78.02%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发